N Verses Capital, LLC Biocryst Pharmaceuticals Inc Transaction History
N Verses Capital, LLC
- $0
- Q4 2024
Shares
2 transactions
Others Institutions Holding BCRX
# of Institutions
277Shares Held
172MCall Options Held
610KPut Options Held
739K-
Vanguard Group Inc Valley Forge, PA21.9MShares$193 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$176 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$105 Million1.3% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$80.1 Million5.66% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY8.14MShares$71.8 Million1.15% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.64B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...